title: Direct oral anticoagulants for acute venous thromboembolism: closing the circle?
authors.affiliation: Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.V.); and the Department of Internal Medicine, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland (H.B.).
authors.forename: Peter
authors.initials: P
authors.lastname: Verhamme
authors.forename: Henri
authors.initials: H
authors.lastname: Bounameaux
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D000069604:Dabigatran; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D054556:Venous Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000008:administration & dosage*; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran
keywords: Editorials; venous thromboembolism; warfarin